Background illustration for clinical trials search

Paid Clinical Trials Fairfield

Discover 2,532 paid clinical trials in Fairfield, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

64Cu-SAR-bisPSMA and 67Cu-SAR-bisPSMA for Identification and Treatment of PSMA-expressing Metastatic Castrate Resistant Prostate Cancer (SECuRE)

for
Prostatic Neoplasms, Castration-Resistant
Location: Stanford CA, Omaha NE, Rochester MN, St Louis MO,
Sponsor: Clarity Pharmaceuticals Ltd

Sex: Male

Age: 18+

Code: NCT04868604

Phase1, Phase2, Recruiting

Study of GS-2121 Given Alone or in Combination in Adults With Advanced Solid Tumors

for
Advanced Solid Tumors
Location: Palo Alto CA, San Antonio TX, Toronto, Fairfax VA,
Sponsor: Gilead Sciences

Sex: All

Age: 18+

Code: NCT06532565

Phase1, Recruiting

A Study of Ziftomenib in Combination With Imatinib in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)

for
Gastrointestinal Stromal Tumor (GIST),
Location: Palo Alto CA, Santa Monica CA, Los Angeles CA,
Sponsor: Kura Oncology, Inc.

Sex: All

Age: 18+

Code: NCT06655246

Phase1, Recruiting

Study of ISB 2001 in Relapsed/Refractory Multiple Myeloma (TRIgnite-1)

for
Relapsed/Refractory Multiple Myeloma
Location: Palo Alto CA, Milwaukee WI, Chicago IL, Atlanta GA,
Sponsor: Ichnos Sciences SA

Sex: All

Age: 18+

Code: NCT05862012

Phase1, Recruiting

Study of KITE-363 or KITE-753 in Participants With Relapsed and/or Refractory B-cell Lymphoma

for
Relapsed and/or Refractory B-cell Lymphoma
Location: Stanford CA, Duarte CA, Gilbert AZ, Austin TX,
Sponsor: Kite, A Gilead Company

Sex: All

Age: 18+

Code: NCT04989803

Phase1, Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome

for
Leukemia, Leukemia, Myeloid, Leukemia, Myeloid, Acute,
Location: Palo Alto CA, Los Angeles CA, Duarte CA, Seattle WA,
Sponsor: BlossomHill Therapeutics

Sex: All

Age: 18+

Code: NCT06501196

Phase1, Recruiting

A Study of Olezarsen for the Treatment of Familial Chylomicronemia Syndrome (FCS) in Pediatric Participants

for
Familial Chylomicronemia Syndrome
Location: San Francisco CA, Fort Worth TX, Dallas TX,
Sponsor: Ionis Pharmaceuticals, Inc.

Sex: All

Age: 2 - 17

Code: NCT07727538

Phase3, Recruiting

ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors

for
Refractory Cancer, Recurrent Cancer, Solid Tumor, Adult, Cancer
Location: Stanford CA, Seattle WA, Aurora CO, Houston TX,
Sponsor: Immatics US, Inc.

Sex: All

Age: 18+

Code: NCT03686124

Phase1, Phase2, Recruiting

Mogamulizumab + Low-Dose Total Skin Electron Beam Tx in Mycosis Fungoides & Sézary Syndrome

for
Sezary Syndrome, Mycosis Fungoides
Location: Stanford CA
Sponsor: Stanford University

Sex: All

Age: 18+

Code: NCT04256018

Phase2, Recruiting

Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors

for
Metastatic Malignant Solid Neoplasm, Metastatic Melanoma,
Location: Stanford CA, Los Angeles CA, Duarte CA
Sponsor: Anusha Kalbasi

Sex: All

Age: 18 - 70+

Code: NCT04119024

Phase1, Recruiting

Safety and Efficacy of OBX-115 in Advanced Solid Tumors

for
Tumor Skin, Metastatic Melanoma, Melanoma, Lung Cancer,
Location: Stanford CA, Los Angeles CA, Houston TX, Louisville KY,
Sponsor: Obsidian Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06060613

Phase1, Phase2, Recruiting

Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors

for
Advanced Cancer
Location: Palo Alto CA, Santa Monica CA, Scottsdale AZ, Tucson AZ,
Sponsor: Riboscience, LLC.

Sex: All

Age: 18+

Code: NCT05270213

Phase1, Recruiting

A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma

for
Metastatic Uveal Melanoma
Location: Palo Alto CA, Los Angeles CA, La Jolla CA, Seattle WA,
Sponsor: Replimune Inc.

Sex: All

Age: 0+

Code: NCT06581406

Phase2, Phase3, Recruiting

Nailbed Repair for Patients With Nailbed Injuries

for
Nail Bed Injury, Nail Laceration, Nail Plate Disruption
Location: Palo Alto CA
Sponsor: Stanford University

Sex: All

Age: 2+

Code: NCT07388823

Recruiting

Brentuximab Vedotin in Early Stage Hodgkin Lymphoma

for
Hodgkin Lymphoma
Location: Stanford CA, Vancouver, Winnipeg, Hamilton, Toronto,
Sponsor: University College, London

Sex: All

Age: 16 - 69

Code: NCT04685616

Phase3, Recruiting

Study of R289 in Patients With Lower-risk Myelodysplastic Syndromes (LR MDS)

for
Low Risk Myelodysplastic Syndromes
Location: Palo Alto CA, Los Angeles CA, Orange CA,
Sponsor: Rigel Pharmaceuticals

Sex: All

Age: 18+

Code: NCT05308264

Phase1, Phase2, Recruiting

A Study of LOXO-783 in Patients With Breast Cancer/Other Solid Tumors

for
Breast Cancer
Location: San Francisco CA, Stanford CA, Vancouver, Dallas TX,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT05307705

Phase1, Recruiting

A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms

for
Myeloproliferative Neoplasms
Location: Palo Alto CA, Duarte CA, Westwood KS, Houston TX,
Sponsor: Incyte Corporation

Sex: All

Age: 18+

Code: NCT06034002

Phase1, Recruiting

CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.

for
Epithelial Ovarian Cancer, Primary Peritoneal,
Location: Palo Alto CA, Santa Barbara CA, Los Angeles CA,
Sponsor: TORL Biotherapeutics, LLC

Sex: Female

Age: 18+

Code: NCT06690775

Phase2, Recruiting

A Phase II Trial of Sacituzumab Govitecan in Patients With Advanced Thymic Epithelial Tumors

for
Thymoma, Thymic Carcinoma
Location: Palo Alto CA, Chicago IL, Washington D.C. DC,
Sponsor: Georgetown University

Sex: All

Age: 18+

Code: NCT06248515

Phase2, Recruiting